A double-blind, placebo-managed research utilised intravenous allogeneic human MSCs in fifty three article-MI individuals, with identical adverse situations involving each teams. Ambulatory EKG confirmed decreased episodes of ventricular tachycardia, and improved forced expiratory volume in a single